Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Breast disease targets and uses thereof

a breast cancer and target technology, applied in the field of molecular markers and therapeutic agents, can solve the problems of high mortality observed in breast cancer patients, and the difficulty of diagnosis and effective treatment of breast cancer

Inactive Publication Date: 2011-04-21
CELERA CORPORATION
View PDF1 Cites 34 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method for diagnosing or detecting breast disease by measuring the level of certain proteins or peptides in a test sample from the subject. These proteins or peptides are differentially expressed in breast cancer cells and can be used as markers for diagnosis. The invention also provides methods for detecting and treating breast disease using antibodies that target these proteins. The invention further provides a method for screening agents that modulate the activity of these proteins. Overall, the invention provides new tools for the diagnosis and treatment of breast disease.

Problems solved by technology

However, the use of established markers is insufficient to interpret the results and it still results in high mortality which is observed in breast cancer patients.
In spite of considerable research into therapies for these and other cancers, breast cancer remains difficult to diagnose and treat effectively.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

working examples

1. Breast Tissues and Cells

[0360]Breast cancer cell lines were obtained from ATTC. Cancer cell line SK-BR-3 (Cat# HTB-30) was cultured in McCoy's 5a medium supplemented with 10% FBS, 1× penicillin-streptomycin-glutamine, and sodium bicarbonate.

[0361]Non-cancer breast cell line MCF-10A (Cat# CRL-10317) was cultured in MEGM (Mammary Epithelial Growth Medium) supplemented with Singlequots that accompany the media.

[0362]All cells were passaged 1-2 times a week. Cancer cells as well as non-cancer cells were disassociated with 0.05% trypsin. Prior to harvesting for experiments, cells were cultured for 48 hours until 75-80% confluency and disassociated with versene. All tissue culture reagents were purchased from BioFluids.

Tissue Processing

[0363]Tissue, both normal and tumor samples, are crudely minced and incubated for 60 minutes with periodic agitation at 37° C. in a buffered enzyme cocktail containing Collagenase and Hyaluronidase. Following digestion, the suspension is further treated ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
sizeaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention provides a method for diagnosing and detecting diseases associated with breast. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in breast diseases (BCAT) and antibodies binds to BCAT. The present invention provides that BCAT is used as targets for screening agents that modulates the BCAT activities. Further the present invention provides methods for treating diseases associated with breast.

Description

FIELD OF THE INVENTION[0001]This invention relates to the fields of molecular biology and oncology. Specifically, the invention provides a molecular marker and a therapeutic agent for use in the diagnosis and treatment of breast diseases.BACKGROUND OF THE INVENTION[0002]Cancer currently constitutes the second most common cause of death in the United States. Carcinomas of the breast are the eighth most prevalent form of cancer and fourth among the most common causes of cancer deaths in this country. The incidence of breast cancer has been increasing steadily in the past twenty years in most industrialized countries, exhibiting the characteristics of a growing epidemiological problem. In the year 2000, for example, an estimated 28,600 deaths will be ascribed to this type of cancer and approximately 28,600 new cases will be diagnosed.[0003]Breast cancer is the primary killer of women. One in eight American women will develop breast cancer in her lifetime. An estimated 3 million women i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/395C07K14/00A61K38/16C07H21/00C07K16/18C12N1/00C12N7/00A01K67/00C12N5/00G01N33/53G01N33/68A61P35/00
CPCA61P35/00G01N33/57415
Inventor HEIDBRINK, JENNYRUBEN, STEVEBIRSE, CHARLES E.HE, TAO
Owner CELERA CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com